跳至主要内容
临床试验/JPRN-UMIN000041441
JPRN-UMIN000041441已完成未知

Validation study of effects of test food ingestion on subjective symptoms and performance after exercise. - Validation study of effects of test food ingestion on subjective symptoms and performance after exercise.

CPCC Company Limited0 个研究点目标入组 20 人开始时间: 2021年8月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 65years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • (1) Those who have previous and/or current medical history of serious disease. (2) Those who habitually take medicines possibly affecting the test results or who can't restrict them. (3) Those who have allergy to medicine and/or food (including allergy to collagen and gelatin). (4) Those who habitually take the following products possibly affecting the test results or those who can not restrict them: Food for Specified Health Uses, Food with Function Claim, Food with Nutrient Function Claim, health foods, dietary supplement, sport nutrition products (e.g., BCAA, Protein, Protein Bar, Protein Drink), energy drinks (e.g., Red Bull), and nutritional drink (e.g., Lipovitan D). (5) Those who have a taste for collagen-rich meals such as "motsu" and "horumon", and actively take them more than 4 times a week. (6) Those who had exercises and/or activities with muscle pain during the last one month before SCR test. (7) Those who plan to have exercises and/or activities with muscle pain during the test period. (8) Those who habitually have body-care. (9) Those who can't participate in the test on schedule. (10) Those who have smoking habit. (11) Those who take a lot of alcohol. (12) Those who have extremely irregular life style. (13) Those who are currently participating in other clinical trials of medicine or health food, or who did within 4-weeks, or who plan to do just after giving informed consent. (14) Those who donated 200 mL of whole blood and/or blood components during the last one month before starting this clinical trial. (15) Those who donated 400 mL of whole blood during the last three months before starting this clinical trial. (16) Those whose total blood collection volume exceeds 1200 mL when the amount of blood collection in the clinical trial and it during the last 12 months before the starting are summed. (17) Those who have been determined ineligible to participate in this study.

研究者

发起方
CPCC Company Limited

相似试验